Kumiai Chemical Industry Co., Ltd. (TYO:4996)
Japan · Delayed Price · Currency is JPY 800.00
+11.00 (1.39%)
Apr 3, 2026, 3:30 PM JST
Kumiai Chemical Industry Income Statement
Financials in millions JPY. Fiscal year is November - October.
Millions JPY. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
| 173,788 | 170,462 | 161,049 | 161,002 | 145,302 | 118,176 | |
Revenue Growth (YoY) | 5.24% | 5.85% | 0.03% | 10.80% | 22.95% | 10.16% |
Cost of Revenue | 138,538 | 136,096 | 125,669 | 124,341 | 111,101 | 89,133 |
Gross Profit | 35,250 | 34,366 | 35,380 | 36,661 | 34,201 | 29,043 |
Selling, General & Admin | 23,701 | 19,317 | 19,568 | 21,066 | 20,054 | 18,990 |
Research & Development | - | 2,005 | 1,701 | 1,504 | 1,415 | 1,461 |
Operating Expenses | 23,729 | 23,640 | 24,097 | 22,646 | 21,456 | 20,584 |
Operating Income | 11,521 | 10,726 | 11,283 | 14,015 | 12,745 | 8,459 |
Interest Expense | -630 | -621 | -417 | -225 | -180 | -141 |
Interest & Investment Income | 354 | 364 | 408 | 730 | 219 | 254 |
Earnings From Equity Investments | 3,734 | 3,247 | 6,697 | 8,664 | 2,224 | 2,073 |
Currency Exchange Gain (Loss) | -807 | -555 | 127 | 493 | 8,470 | 1,900 |
Other Non Operating Income (Expenses) | 370 | 202 | 202 | 438 | 93 | 283 |
EBT Excluding Unusual Items | 14,542 | 13,363 | 18,300 | 24,115 | 23,571 | 12,828 |
Gain (Loss) on Sale of Investments | 13 | 13 | -1,024 | -355 | -6 | 280 |
Gain (Loss) on Sale of Assets | -149 | -154 | -241 | -351 | -114 | -235 |
Asset Writedown | -3,978 | -3,978 | -236 | -491 | -43 | -55 |
Other Unusual Items | -165 | -158 | 182 | 402 | -289 | -399 |
Pretax Income | 10,263 | 9,086 | 16,981 | 23,320 | 23,119 | 12,419 |
Income Tax Expense | 6,177 | 4,870 | 3,120 | 4,893 | 6,411 | 3,187 |
Earnings From Continuing Operations | 4,086 | 4,216 | 13,861 | 18,427 | 16,708 | 9,232 |
Minority Interest in Earnings | 235 | 165 | -271 | -403 | -379 | -209 |
Net Income | 4,321 | 4,381 | 13,590 | 18,024 | 16,329 | 9,023 |
Net Income to Common | 4,321 | 4,381 | 13,590 | 18,024 | 16,329 | 9,023 |
Net Income Growth | -71.39% | -67.76% | -24.60% | 10.38% | 80.97% | 36.34% |
Shares Outstanding (Basic) | 120 | 120 | 120 | 120 | 121 | 125 |
Shares Outstanding (Diluted) | 120 | 120 | 120 | 120 | 121 | 125 |
Shares Change (YoY) | 0.04% | 0.04% | 0.09% | -0.25% | -3.62% | 0.01% |
EPS (Basic) | 35.88 | 36.38 | 112.91 | 149.89 | 135.45 | 72.14 |
EPS (Diluted) | 35.88 | 36.38 | 112.91 | 149.89 | 135.45 | 72.14 |
EPS Growth | -71.41% | -67.78% | -24.67% | 10.66% | 87.77% | 36.32% |
Free Cash Flow | - | 25,526 | -25,741 | -3,930 | -8,976 | -2,149 |
Free Cash Flow Per Share | - | 212.00 | -213.87 | -32.68 | -74.45 | -17.18 |
Dividend Per Share | 24.000 | 24.000 | 34.000 | 45.000 | 22.000 | 15.000 |
Dividend Growth | -29.41% | -29.41% | -24.44% | 104.55% | 46.67% | 25.00% |
Gross Margin | 20.28% | 20.16% | 21.97% | 22.77% | 23.54% | 24.58% |
Operating Margin | 6.63% | 6.29% | 7.01% | 8.71% | 8.77% | 7.16% |
Profit Margin | 2.49% | 2.57% | 8.44% | 11.20% | 11.24% | 7.63% |
Free Cash Flow Margin | - | 14.97% | -15.98% | -2.44% | -6.18% | -1.82% |
EBITDA | 18,053 | 17,081 | 17,199 | 19,103 | 17,582 | 12,777 |
EBITDA Margin | 10.39% | 10.02% | 10.68% | 11.87% | 12.10% | 10.81% |
D&A For EBITDA | 6,532 | 6,355 | 5,916 | 5,088 | 4,837 | 4,318 |
EBIT | 11,521 | 10,726 | 11,283 | 14,015 | 12,745 | 8,459 |
EBIT Margin | 6.63% | 6.29% | 7.01% | 8.71% | 8.77% | 7.16% |
Effective Tax Rate | 60.19% | 53.60% | 18.37% | 20.98% | 27.73% | 25.66% |
Updated Jan 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.